On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
John Kassis, PharmD
Advertisement
Articles by John Kassis, PharmD
Advertisement
Latest Updated Articles
Barhemsys (Amisulpride) for Postoperative Nausea and VomitingPublished: June 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
2
Orforglipron Demonstrates Superior Glycemic Control for Type 2 Diabetes
3
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
4
FDA Approves First 1-Minute Self Test for HIV
5
